| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Revenue | $22.10B | +8.2% |
| R&D Expense | $617.0M | +14.5% |
| SG&A Expense | $3.30B | +31.3% |
| Operating Income | $2.30B | -49.1% |
| Interest Expense | $362.0M | +19.9% |
| Pre-tax Income | $2.08B | -51.4% |
| Income Tax | $644.0M | -9.0% |
| Net Income | $1.44B | -59.3% |
| EPS (Basic) | $1.61 |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $10.02B | +184.5% |
| Accounts Receivable | $2.48B | -12.4% |
| Inventory | $2.22B | -16.0% |
| Current Assets | $18.78B | +90.1% |
| Total Assets | $32.82B | +25.8% |
| Current Liabilities | $6.89B | +14.2% |
| Long-term Debt | $14.24B | +63.7% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $2.61B | +49.6% |
| Investing Cash Flow | -$660.0M | -137.8% |
| Financing Cash Flow | $4.61B | +257.4% |
| -61.6% |
| EPS (Diluted) | $1.58 | -61.5% |
| Total Liabilities |
| $23.82B |
| +32.2% |
| Stockholders' Equity | $9.01B | +11.5% |